ITM, Helmholtz Munich and University Hospital Münster Announce First Patient Dosed in Phase I Investigator-Initiated Glioblastoma Trial
GlobeNewswire
*A Novel Therapeutic Approach to Treatment using ITM-31**Garching/Munich, Munich and Münster, **April 23, 2024 – *The..